Effect of non-peptide tachykinin NK1 receptor antagonists on non-adrenergic, non-cholinergic neurogenic mucus secretion in ferret trachea

被引:18
|
作者
Khawaja, AM [1 ]
Liu, YC [1 ]
Rogers, DF [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England
关键词
CGP; 49823; 55000; CP 99,994; MEN 10,627; mucus; tachykinin; tachykinin receptor; tachykinin receptor antagonist;
D O I
10.1016/S0014-2999(99)00694-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated, in ferret trachea in vitro, the binding characteristics and the inhibition of non-adrenergic, non-cholinergic (NANC) neural mucus secretion of four tachykinin receptor antagonists: the non-peptide tachykinin NK1 receptor antagonists CGP 49823 ((2R,4S)-2-benzyl-1-(3,5-dimethylbenzoyl)-4-(quinolin-mu-ylmethl amino) piperidine) and CGP 55000 ((2R,4S)-2-benzyl-1-(3,5-bistrifluoromethyl-benzoyl)-4-(quinolinyl-methylamino)piperidine) and CP 99,994 ((+)-(2S,3S)-3-methoxybenzyl amino)-2-phenylpiperidine), and the peptide tachykinin NK2 receptor antagonist MEN 10,627 (cyclo(Met-Asp-Trp-Phe-Dap-Leu)cyclo(2 beta-5 beta)). CGP 49823, CGP 55000 and CP 99,994 concentration-dependently displaced [I-125]Bolton-Hunter substance P binding in tracheal membranes with Hill coefficients not different from unity and IC50 values of 1.4, 1.7 and 1.3 nM, respectively. In contrast, MEN 10,627 displaced binding according to a two-site model, with IC(50)s of 0.2 nM and 1.3 mu M. Electrical stimulation of tracheal segments with adrenoceptor and cholinoceptor blockade increased output of the mucus marker (SO4)-S-35 by 59% above baseline (representing the NANC neural secretory response). CGP 49823, CGP 55000 or CP 99,994 concentration-dependently inhibited NANC neural secretion with IC50 values of 30, 8 and 120 nM, respectively. In contrast, MEN 10,627 (3 mu M) did not inhibit secretion. The NK1 antagonists, but not the NK2 antagonist, inhibited [Sar(9)]substance P-induced secretion, while none of the antagonists affected acetylcholine-induced secretion. We conclude that NANC neural secretion in ferret trachea in vitro is a useful test system for tachykinin NK1 receptor antagonists with therapeutic potential in conditions of the airways in which tachykininergic mechanisms and mucus hypersecretion are implicated in pathophysiology, for example asthma and chronic bronchitis. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:173 / 181
页数:9
相关论文
共 50 条
  • [21] Effect of sildenafil on non-adrenergic non-cholinergic neurotransmission in bovine penile small arteries
    Simonsen, U
    Contreras, J
    García-Sacristán, A
    Martinez, AC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 412 (02) : 155 - 169
  • [22] The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system
    Polley, JS
    Gaskin, PJ
    Perren, MJ
    Connor, HE
    Ward, P
    Beattie, DT
    REGULATORY PEPTIDES, 1997, 68 (01) : 23 - 29
  • [23] The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist
    Beattie, DT
    Beresford, IJM
    Connor, HE
    Marshall, FH
    Hawcock, AB
    Hagan, RM
    Bowers, J
    Birch, PJ
    Ward, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (08) : 3149 - 3157
  • [24] IS VIP THE PUTATIVE NON-CHOLINERGIC, NON-ADRENERGIC NEUROTRANSMITTER CONTROLLING PROTEIN SECRETION IN RAT LACRIMAL GLANDS
    HUSSAIN, M
    SINGH, J
    QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES, 1988, 73 (01): : 135 - 138
  • [25] The effect of guanylate cyclase inhibitors on non-adrenergic and non-cholinergic neurogenic relaxations of the South American opossum lower esophageal sphincter
    Matsuda, Nilce Mitiko
    Lemos, Moyses Costa
    Feitosa, Rui Liborio, Jr.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 (03) : 299 - 304
  • [26] PEPTIDE HISTIDINE ISOLEUCINE AS POSSIBLE NON-ADRENERGIC NON-CHOLINERGIC INHIBITORY NEUROTRANSMITTER IN THE RAT GASTRIC FUNDUS
    DAMATO, M
    CURRO, D
    LEFEBVRE, RA
    REGULATORY PEPTIDES, 1989, 26 (02) : 150 - 150
  • [27] CONTROL OF ENZYME-SECRETION BY NON-CHOLINERGIC, NON-ADRENERGIC NERVES IN GUINEA-PIG PANCREAS
    PEARSON, GT
    DAVISON, JS
    COLLINS, RC
    PETERSEN, OH
    NATURE, 1981, 290 (5803) : 259 - 261
  • [28] Effect of fenspiride, a non-steroidal antiinflammatory agent, on neurogenic mucus secretion in ferret trachea in vitro
    Khawaja, AM
    Liu, YC
    Rogers, DF
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 1999, 12 (06) : 363 - 368
  • [29] INFLUENCE OF VIP ANTISERUM AND VIP ANTAGONISTS ON THE EFFECT OF VIP AND OF NON-ADRENERGIC NON-CHOLINERGIC NEURON STIMULATION IN THE CAT GASTRIC FUNDUS
    DAMATO, M
    DEBEURME, FA
    LEFEBVRE, RA
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1988, 20 (05): : 421 - 422
  • [30] Modulatory effect of dopamine on non-adrenergic, non-cholinergic (NANC) transmission in the mouse distal colon
    Sharabi, FM
    El-Gowelly, SM
    El-Din, M
    FASEB JOURNAL, 2000, 14 (04): : A387 - A387